Shirley R. Kuhlmann - Mar 4, 2025 Form 4 Insider Report for COLLEGIUM PHARMACEUTICAL, INC (COLL)

Role
EVP and General Counsel
Signature
/s/ Shirley R. Kuhlmann
Stock symbol
COLL
Transactions as of
Mar 4, 2025
Transactions value $
-$1,465,434
Form type
4
Date filed
3/6/2025, 06:48 PM
Previous filing
Feb 12, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COLL Common Stock Options Exercise $961K +40K +25.94% $24.03 194K Mar 4, 2025 Direct
transaction COLL Common Stock Sale -$1.12M -40K -20.6% $28.08 154K Mar 4, 2025 Direct F1
transaction COLL Common Stock Sale -$561K -20K -12.97% $28.03 134K Mar 5, 2025 Direct F2
transaction COLL Common Stock Sale -$743K -26.1K -19.42% $28.50 108K Mar 6, 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction COLL Stock Option (Right to Purchase) Options Exercise $0 -40K -100% $0.00 0 Mar 4, 2025 Common Stock 40K $24.03 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Shirley R. Kuhlmann is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.00 to $28.24, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (2) and (3) to this Form 4.
F2 The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.00 to $28.18, inclusive.
F3 The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $28.50 to $28.58, inclusive.
F4 The option is fully vested and exercisable.